Brazil suspends distribution of 12 million Sinovac vaccines

“In these terms, vaccines packaged in a place not approved in the authorization for emergency use are considered an unregulated product for Anvisa ”, detailed the agency in a press release.

The affected lots, which include vaccines yet to arrive in Brazil, represent more than 12 million doses of the coronavirus compound, the first to be approved for emergency use in the country along with the vaccine from AstraZeneca.

In the statement, Anvisa clarified that she had not found any assessment of the plant’s quality standards by other health organizations.

The agency assured that it will devote this period to the assessment of the good practice standards of the plant in question, as well as the possible impact on the population that has already been vaccinated with herds from the same location.

In Brazil, the second country in the world with the most deaths recorded by Covid-19 and the fifth with the most cases, around 65 million people are immunized with the full schedule of one of the vaccines, or only 30% of the population. to data from Johns Hopkins University.